Related Experiment Video
Updated: Aug 19, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcome
Erwin Stolz1, Anousha Rahimi, Tibo Gerriets
1Department of Neurology, Justus-Liebig-University, Am Steg 14, D-35385 Giessen, Germany. Erwin.stolz@neuro.med.uni-giessen.de
Insights
Cerebral venous thrombosis (CVT) patients show a good prognosis after surviving the acute phase, with most achieving favorable functional outcomes. Long-term complications like epilepsy and recurrent thrombosis are possible but manageable.
Area of Science:
- Neurology
- Vascular Medicine
- Clinical Outcomes Research
Background:
- Limited data exists on the short- and long-term prognosis of cerebral venous thrombosis (CVT).
- Understanding prognosis is crucial for patient management and treatment strategies.
Purpose of the Study:
- To analyze factors influencing acute death and functional outcomes in CVT patients.
- To evaluate the long-term prognosis of cerebral venous thrombosis.
Main Methods:
- A cohort of 79 consecutive patients with CVT was studied.
- Neurological deficits were assessed using the National Institutes of Health Stroke Scale (NIHSS), and functional outcomes were measured with the modified Rankin Scale (mRS).
- Data included acute death, 6-month functional outcome, and complications over a follow-up period exceeding 12 months.
Main Results:
- Factors associated with acute death included age, NIHSS score, seizures, venous infarct, and hemorrhagic transformation.
- At 6 months, 73% of patients achieved an excellent outcome (mRS 0-1).
- Long-term follow-up revealed epilepsy in 9 patients and recurrent venous thrombosis in 7 patients.
Conclusions:
- Cerebral venous thrombosis (CVT) carries a favorable prognosis once the acute phase is overcome.
- The long-term outlook for CVT survivors is generally good, contrasting with arterial ischemic stroke.
- Epilepsy and recurrent CVT are notable long-term complications.
Background:
There is insufficient data on short- and especially long-term prognosis of cerebral venous thrombosis (CVT).
Methods:
In 79 consecutive patients, we analyzed factors for acute death and functional outcome at hospital discharge and after 6 months as well as long-term prognosis >/=12 months. Neurological deficits were graded on the National Institute of Health Stroke Scale (NIHSS), functional outcome on the modified Rankin Scale (mRS). Primary outcome was defined as mRS >/= 3 at 6 months, secondary outcomes were death during hospital treatment and number as well as type of complications during follow-up >/=12 months after hospital discharge. Forty-two patients were recruited prospectively, 37 were identified by chart review. Information on outcome was based on neurological examinations at our outpatient clinic.
Results:
Factors significantly related to acute death were age, the NIHSS on admission, more than two seizures despite antiepileptic treatment, venous infarct, and hemorrhagic transformation of the venous infarct. Primary outcome after 6 months in 74 patients was excellent with 73% of patients reaching a mRS 0-1, 4% a mRS of 2, and 23% a mRS 3-6, including 12 deaths in the acute stage of illness. Factors significantly related to a mRS >/= 3 at 6 months in a logistic regression analysis were age and items 1a-c of the NIHSS on admission related to consciousness. Fifty-eight surviving patients had a follow-up >/= 12 months (median: 31; mean: 52 +/- 61 months). Most frequent complication on long-term follow-up was epilepsy in nine patients and recurrent venous thrombosis in seven patients.
Conclusions:
When the acute stage of illness has been survived, CVT has a good prognosis unlike arterial ischemic stroke.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Venous Thrombosis III: Interprofessional Care
Cerebral Edema ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology